Allovir (NASDAQ:KLRS) Stock Rating Upgraded by Wall Street Zen
Allovir (NASDAQ:KLRS – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Sunday. Allovir Stock Performance Shares of KLRS opened at $2.92 on Friday. Allovir has a twelve month low of $2.64 and a twelve month high […]
